AssetMark Inc
MRNA icon

AssetMark Inc’s Moderna MRNA Stock Holding History

AssetMark Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.9K Sell
798
-3
-0.4% -$155 ﹤0.01% 1799
2026
Q1 		$40.7K Buy
801
+208
+35% +$9.7K ﹤0.01% 1819
2025
Q4 		$17.5K Sell
593
-531
-47% -$14.4K ﹤0.01% 2041
2025
Q3 		$29K Sell
1,124
-174
-13% -$4.85K ﹤0.01% 1819
2025
Q2 		$35.8K Buy
1,298
+752
+138% +$19.8K ﹤0.01% 1656
2025
Q1 		$15.5K Buy
546
+179
+49% +$6.35K ﹤0.01% 1757
2024
Q4 		$15.2K Buy
367
+136
+59% +$6.5K ﹤0.01% 1712
2024
Q3 		$15.4K Sell
231
-45,938
-99% -$4.22M ﹤0.01% 1552
2024
Q2 		$5.48M Sell
46,169
-3,469
-7% -$439K 0.02% 416
2024
Q1 		$5.29M Sell
49,638
-569,514
-92% -$57.4M 0.02% 402
2023
Q4 		$61.6M Buy
619,152
+403,428
+187% +$33.9M 0.22% 97
2023
Q3 		$22.3M Buy
215,724
+47,667
+28% +$5.32M 0.09% 178
2023
Q2 		$20.4M Sell
168,057
-309,310
-65% -$41.3M 0.08% 189
2023
Q1 		$73.3M Buy
477,367
+262,782
+122% +$43.4M 0.3% 70
2022
Q4 		$38.5M Sell
214,585
-15,251
-7% -$2.49M 0.17% 130
2022
Q3 		$27.2M Buy
229,836
+2,193
+1% +$333K 0.13% 142
2022
Q2 		$32.5M Buy
227,643
+2,285
+1% +$327K 0.15% 137
2022
Q1 		$38.8M Buy
225,358
+186,660
+482% +$31.4M 0.16% 131
2021
Q4 		$9.83M Buy
38,698
+38,450
+15,504% +$11.2M 0.04% 222
2021
Q3 		$95K Buy
248
+238
+2,380% +$87.8K ﹤0.01% 654
2021
Q2 		$2K Buy
+10
New +$1.79K ﹤0.01% 1208

Other funds holding MRNA

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

AssetMark Inc's MRNA Position: Q2 2026 in Review

AssetMark Inc reduced its Moderna (MRNA) stake by 0.37% in Q2 2026, selling an estimated $155 and leaving 798 shares worth $55.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1799.

AssetMark Inc first reported a position in MRNA in Q2 2021 and has held it in 21 quarters since. The position peaked at $73.3M in Q1 2023. 299 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • AssetMark Inc held 798 shares of Moderna worth $55.9K as of Q2 2026.
  • AssetMark Inc sold 3 Moderna shares in Q2 2026, an estimated $155.
  • Moderna made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1799 holding.
  • AssetMark Inc first reported a position in Moderna in Q2 2021 and has held it in 21 quarters since.
  • AssetMark Inc's Moderna position peaked at $73.3M in Q1 2023.
  • 299 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.